S&P 500   2,715.33 (+1.94%)
DOW   23,156.75 (+2.10%)
QQQ   199.43 (+1.50%)
AAPL   263.11 (+0.24%)
FB   170.58 (+3.04%)
MSFT   166.49 (+0.74%)
GOOGL   1,197.35 (+1.20%)
CGC   14.75 (+2.86%)
NVDA   265.68 (-1.01%)
BABA   199.41 (+1.51%)
MU   47.55 (+2.54%)
GE   7.24 (+0.00%)
TSLA   552.19 (+6.96%)
AMD   49.00 (+3.11%)
T   30.48 (+3.53%)
ACB   0.82 (+2.50%)
F   4.84 (+6.84%)
NFLX   376.42 (-0.93%)
BAC   22.49 (+5.14%)
GILD   74.75 (-3.83%)
DIS   102.74 (+3.17%)
S&P 500   2,715.33 (+1.94%)
DOW   23,156.75 (+2.10%)
QQQ   199.43 (+1.50%)
AAPL   263.11 (+0.24%)
FB   170.58 (+3.04%)
MSFT   166.49 (+0.74%)
GOOGL   1,197.35 (+1.20%)
CGC   14.75 (+2.86%)
NVDA   265.68 (-1.01%)
BABA   199.41 (+1.51%)
MU   47.55 (+2.54%)
GE   7.24 (+0.00%)
TSLA   552.19 (+6.96%)
AMD   49.00 (+3.11%)
T   30.48 (+3.53%)
ACB   0.82 (+2.50%)
F   4.84 (+6.84%)
NFLX   376.42 (-0.93%)
BAC   22.49 (+5.14%)
GILD   74.75 (-3.83%)
DIS   102.74 (+3.17%)
S&P 500   2,715.33 (+1.94%)
DOW   23,156.75 (+2.10%)
QQQ   199.43 (+1.50%)
AAPL   263.11 (+0.24%)
FB   170.58 (+3.04%)
MSFT   166.49 (+0.74%)
GOOGL   1,197.35 (+1.20%)
CGC   14.75 (+2.86%)
NVDA   265.68 (-1.01%)
BABA   199.41 (+1.51%)
MU   47.55 (+2.54%)
GE   7.24 (+0.00%)
TSLA   552.19 (+6.96%)
AMD   49.00 (+3.11%)
T   30.48 (+3.53%)
ACB   0.82 (+2.50%)
F   4.84 (+6.84%)
NFLX   376.42 (-0.93%)
BAC   22.49 (+5.14%)
GILD   74.75 (-3.83%)
DIS   102.74 (+3.17%)
S&P 500   2,715.33 (+1.94%)
DOW   23,156.75 (+2.10%)
QQQ   199.43 (+1.50%)
AAPL   263.11 (+0.24%)
FB   170.58 (+3.04%)
MSFT   166.49 (+0.74%)
GOOGL   1,197.35 (+1.20%)
CGC   14.75 (+2.86%)
NVDA   265.68 (-1.01%)
BABA   199.41 (+1.51%)
MU   47.55 (+2.54%)
GE   7.24 (+0.00%)
TSLA   552.19 (+6.96%)
AMD   49.00 (+3.11%)
T   30.48 (+3.53%)
ACB   0.82 (+2.50%)
F   4.84 (+6.84%)
NFLX   376.42 (-0.93%)
BAC   22.49 (+5.14%)
GILD   74.75 (-3.83%)
DIS   102.74 (+3.17%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Corvus PharmaceuticalsXeris PharmaceuticalsProMetic Life SciencesTapImmuneAcelRx Pharmaceuticals
SymbolNASDAQ:CRVSNASDAQ:XERSOTCMKTS:PFSCFNASDAQ:MRKRNASDAQ:ACRX
Price Information
Current Price$2.05$1.88$0.01$1.72$1.28
52 Week RangeBuyBuyHoldBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyBuy
Consensus Price Target$7.75$16.00N/A$10.33$6.38
% Upside from Price Target278.05% upside751.06% upsideN/A500.78% upside397.97% upside
Trade Information
Market Cap$61.89 million$74.76 million$338,000.00$83.29 million$84.43 million
Beta2.041.152.460.21.66
Average Volume154,493568,729174293,3001,222,494
Sales & Book Value
Annual RevenueN/A$2.72 million$36.55 million$210,000.00$2.29 million
Price / SalesN/A25.970.01381.1044.95
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$2.42 per share$0.53 per share($67.63) per share$0.96 per share($0.52) per share
Price / BookN/A3.550.001.79-2.46
Profitability
Net Income$-46,670,000.00$-125,580,000.00$-150,730,000.00$-21,430,000.00$-53,240,000.00
EPS($1.59)($4.81)N/A($0.47)($0.67)
Trailing P/E RatioN/AN/A0.00N/AN/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-4,568.21%-894.02%N/A-2,325.91%
Return on Equity (ROE)-54.61%-209.32%-3,350.55%-43.07%N/A
Return on Assets (ROA)-47.68%-94.43%-67.76%-40.48%-50.12%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.03%4.04%N/A0.01%N/A
Current Ratio7.76%3.20%0.95%22.82%5.27%
Quick Ratio7.76%3.12%0.71%22.82%5.02%
Ownership Information
Institutional Ownership Percentage70.89%46.94%0.10%33.21%23.03%
Insider Ownership Percentage40.40%7.43%N/A23.70%7.50%
Miscellaneous
Employees49904871161
Shares Outstanding29.33 million37.57 million23.31 million46.53 million80.41 million
Next Earnings Date5/14/2020 (Estimated)5/14/2020 (Estimated)N/A5/14/2020 (Estimated)5/13/2020 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel